I find that an intensely informative post, Guts, and is well set out. You have recounted your experience of pharma stocks over the years, and testified on just how easy it is to get out too early, when a company has a solid foundation, has one or more increasing revenue streams and knows how to find new opportunities. All those considerations are directly relevant to ScripsAmerica – especially when a large number of naysayers and skeptics devote so much time and attention to this board.
In addition, I find Bsav's latest posts to be right on target in reminding everyone here of the techniques used to generate fear, anxiety, boundless worry, while eroding shareholdrs' patience and their attention to facts and known data.